This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Department of Health and Human Services (HHS) owns a patent for a cannabis-related invention. In July of this year, United Cannabis Corporation (UCANN) filed a patentinfringement action in federal court in Colorado against Pure Hemp Collective Inc. United Cannabis Corp. Pure Hemp Collective Inc. 1:18-cv-01922-NYW (D.Colo)).
Patent assertion finance today is a multibillion-dollar business. [2] 2] Virtually nonexistent in the patent space in the U.S. 20] (The orders apply to all parties and litigation before his Court, not just parties to patent disputes, but do not extend, as yet, to the other sitting judges there.) 2d 217, 221 (Ohio 2003).
Chief Judge Connolly of the District of Delaware had initiated an inquiry into dozens of patentinfringement cases filed by plaintiff LLCs associated with IP Edge, a patent monetization firm, and Mavexar, an affiliated consulting shop. 2003) (witness testimony important). Canary Connect, Inc. , Ashcroft , 353 F.3d
It identifies the product of that company and recognizes its own and gives some rights to ownership that can be enforced. PatentInfringement. It also protects the product from unauthorized use by a third party. This can a lesson for the companies interested in the metaverse. Conclusion and Suggestions.
Through its acquisition of BioVeris Corporation, Roche Diagnostics became the owner of various patents relating to immunoassays employing electrochemiluminescence (“ECL”). The decision raises interesting issues relating to induced patentinfringement and the interpretation of a licensing provision.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content